- ►annals.org J Concato, D Jain, E Uchio, H Risch, WW Li, … - Annals of Internal Medicine, 2009 - Am Coll Physicians Objective: To determine whether molecular markers of cell cycle regulation
(bcl-2 and p53) and angiogenesis (β-3 integrin, vascular endothelial growth
factor, and microvessel density) are associated with increased long-term ... Cited by 3 - Related articles - All 4 versions
K REVELOS, C PETRAKI, A SCORILAS, S … - Anticancer research, 2007 - ar.iiarjournals.org The aim of this study was to elucidate the prognostic value of the
immunohistochemical detection of the androgen receptor (AR) status, the
chromogranin A assessment of neuroendocrine differentiation (NED) and the ... Cited by 5 - Related articles - BL Direct - All 4 versions
J Concato, D Jain, WW Li, HA Risch, EM … - BJU International-British Journal of Urology, 2007 - acfw.com.br NO CLAIM TO ORIGINAL US GOVERNMENT WORKS ... PROGNOSIS IN PROSTATE CANCER
CONCATO et al. ... Molecular markers and mortality in prostate cancer ... John
Concato*†, Dhanpat Jain‡, William W. Li§, Harvey A. Risch¶, Edward M. ... Cited by 14 - Related articles - View as HTML - BL Direct - All 4 versions
JT Lee, BD Lehmann, DM Terrian, WH Chappell … - Cell cycle (Georgetown, Tex.), 2008 - pubmedcentral.nih.gov Prostate cancer remains a leading cause of death in men despite increased
capacity to diagnose at earlier stages. After prostate cancer has become hormone
independent, which often occurs after hormonal ablation therapies, it is ... Cited by 9 - Related articles - All 5 versions
T Schlomm, A Erbersdobler, M Mirlacher, G … - World Journal of Urology, 2007 - Springer Page 1. World J Urol (2007) 25:19–30 DOI 10.1007/s00345-007-0153-z 123 TOPIC
PAPER Molecular staging of prostate cancer in the year 2007 ... Cited by 10 - Related articles - BL Direct - All 3 versions
- ►x01.us [PDF] EP Gelmann - New England Journal of Medicine, 2008 - content.nejm.org Susceptibility to prostate cancer has a clear heritable component: men are at an
increased risk for the disease if they have a first-degree relative with
prostate cancer. The more relatives a man has with the disease, the greater ... Cited by 10 - Related articles - BL Direct - All 7 versions
A Kamath, M Helie, CB Bifulco, WW Li, J … - Applied Immunohistochemistry & Molecular …, 2009 - journals.lww.com Background: Vascular endothelial growth factor (VEGF) has been implicated in
tumor angiogenesis and is a potential therapeutic target in prostatic
adenocarcinoma (PrCa). Immunohistochemical (IHC) analysis has been used to ... Cited by 1 - Related articles - All 2 versions
A Erbersdobler, H Isbarn, K Dix, I Steiner, T … - World Journal of Urology - Springer Abstract Purpose Angiogenesis is an important part in tumor progression and
intratumoral microvessel density (MVD) has proven a prognostic factor in several
solid tumors. However, its value in prostate cancer is still unclear, espe- ... Related articles - All 2 versions
